http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-71939-U
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b4b043c903ec3d696709ca6140213988 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-00 |
| filingDate | 2012-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bebee50fc1f94e18f1cfa85a9779f673 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04246d953169c562cba0e2675cd3c873 |
| publicationDate | 2012-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | UA-71939-U |
| titleOfInvention | METHOD OF ASSESSMENT OF THE EFFECTIVENESS OF ANTIGIPERTENSIVE ACTION OF OLMESARTAN IN COMBINATION WITH INDAPAMID IN PATIENTS WITH ARTERIAL HYPERTENSION THROUGH ORIGIN |
| abstract | A method for evaluating the effectiveness of the antihypertensive effect of olmesartan in combination with indapamide in patients with arterial hypertension, which includes determining plasma markers of correlation with blood pressure, and when arterial hypertension occurs against the background of obesity, the concentration of ghrelin in the blood plasma is determined and when it increases to 25 , 6 ± 6.5 pg / ml and higher during treatment with a combination of olmesartan with indapamide, this is regarded as a manifestation of an antihypertensive effect. |
| priorityDate | 2012-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 15.